« Previous Next » Journal of Vascular Surgery
Volume 50, Issue 5 , Pages 999-1004 , November 2009

Acute management of aortobronchial and aortoesophageal fistulas using thoracic endovascular aortic repair

Frederik H.W. Jonker, MD
- Section of Vascular Surgery, Department of Surgery at Yale University School of Medicine, New Haven, Conn
Robin Heijmen, MD, PhD
- Department of Cardiothoracic Surgery, St Antonius Hospital, Nieuwegein, The Netherlands
Santi Trimarchi, MD
- Cardiovascular Center “E Malan,” Policlinico San Donato IRCCS, San Donato Milanese, Italy
Hence J.M. Verhagen, MD, PhD
- Department of Vascular Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands
Frans L. Moll, MD, PhD
- Section of Vascular Surgery, Department of Surgery at the University Medical Center Utrecht, Utrecht, The Netherlands
Bart E. Muhs, MD, PhD
- Sections of Vascular Surgery and Interventional Radiology, Departments of Surgery and Radiology at Yale University School of Medicine, New Haven, Conn
- Reprint requests: Bart E. Muhs, MD, PhD, Assistant Professor of Surgery and Radiology, Co-Director, Endovascular Program, Yale University School of Medicine, 333 Cedar St, BB-204, New Haven, CT 06510

Received 3 March 2009 ,Accepted 17 April 2009.

Survival after TEVAR for aortobronchial fistula (ABF) and aortoesophageal fistula (AEF) (N = 11). This Fig depicts the survival after thoracic endovascular aneurysm repair (TEVAR) for ABF and AEF. No

Survival after TEVAR for aortobronchial fistula (ABF) and aortoesophageal fistula (AEF) (N = 11). This Fig depicts the survival after thoracic endovascular aneurysm repair (TEVAR) for ABF and AEF. No deaths occurred after 3 months. Median follow-up of surviving patients was 45 months (range, 3 to 61 months; interquartile range, 45 months).
- Full-Size Image
- Download to PowerPoint